Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manolete PartnersMANOF 79 14-Day RSI is 85.90 as of Jul. 19, 2026. GuruFocus rates MANOF with a GF Score™ of 79/100 and a GF Value™ of $1.64 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,128 Business Services companies, Manolete Partners ranks worse than 73.67% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Manolete Partners 14-Day RSI Related Terms
MANOF vs VRSK, EFX, BAH: 14-Day RSI Comparison
For the Consulting Services subindustry, Manolete Partners's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manolete Partners 14-Day RSI vs Business Services Industry
For the Business Services industry and Industrials sector, Manolete Partners's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Manolete Partners's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manolete Partners (MANOF) has a 14-Day RSI of 85.90 as of Jul. 19, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Manolete Partners and its competitors. According to the industry distribution chart, Manolete Partners ranks #831 out of 1128 companies in the Business Services industry, placing it in the top 73.7%.
Is Manolete Partners' 14-Day RSI too high?
Manolete Partners' current 14-Day RSI is 85.90. The Business Services industry median 14-Day RSI is 50.01. Manolete Partners' value of 85.90 is 71.8% above this industry median. Based on the distribution chart, Manolete Partners ranks #831 out of 1128 companies in the Business Services industry, which is below the industry midpoint. Overall, Manolete Partners has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Manolete Partners' 14-Day RSI compare to VRSK and EFX?
According to the Business Services industry distribution chart, Manolete Partners ranks #831 out of 1128 companies for 14-Day RSI. This places Manolete Partners in the lower half of its industry. The industry median 14-Day RSI is 50.01. Manolete Partners' value of 85.90 is 71.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Business Services company?
The median 14-Day RSI among Business Services companies is 50.01, based on 1,128 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Manolete Partners's current 14-Day RSI of 85.90 is 71.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Manolete Partners and its competitors. For the Business Services industry, the median 14-Day RSI is 50.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manolete Partners's current 14-Day RSI is 85.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manolete Partners stock overvalued right now?
Based on GuruFocus' analysis, Manolete Partners (MANOF) is currently considered Significantly Undervalued. The stock's GF Value™ is $1.64, compared to a current price of $0.60 — trading 63.2% below its estimated fair value. The current 14-Day RSI is 85.90 and 71.8% above the Business Services industry median of 50.01. Manolete Partners' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Manolete Partners (MANOF), the current 14-Day RSI is 85.90 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Manolete Partners (MANOF) Overvalued in 2026?
Based on GuruFocus' analysis, Manolete Partners stock appears to be undervalued.
The current stock price of $0.60 is trading 63.2% below its estimated GF Value™ of $1.64.
GuruFocus considers Manolete Partners to be Significantly Undervalued.
Key valuation signals for MANOF:
14-Day RSI: 85.90
GF Value™: $1.64 vs. price of $0.60 (63.2% below fair value)
Industry Position: 71.8% above the Business Services median (#831 of 1128)
No single metric tells the full story. See the MANOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Manolete Partners PLC is a United Kingdom-based company. The principal activity of the company is the acquisition and funding of insolvency litigation.
79GF Score
Get the complete analysis for MANOF
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MANOF has been successfully added to your 
